Fluarix Tetra

Fluarix Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by GlaxoSmithKline Biologicals S.A.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the Influenza Virus B/Austria/1359417/2020. This vaccine is typically administered annually to help reduce the risk of flu infection and its complications. It is often recommended for individuals who are at higher risk of severe flu symptoms, such as the elderly, young children, and those with chronic health conditions.

Common effects of Fluarix Tetra may include soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or muscle aches following vaccination. These effects are usually temporary and resolve within a few days.

Fluarix Tetra should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of the components should avoid this vaccine. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine.

Fluarix Tetra may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Fluarix Tetra. Additionally, individuals with weakened immune systems should consult their healthcare provider for personalized advice.